Key result
Comprehensive internal medicine strategies are essential to mitigate elevated CV risk in CKD.
Why the study?
Chronic Kidney Disease is intricately linked to cardiovascular morbidity and mortality, with a complex bidirectional relationship requiring comprehensive internal medicine approaches to mitigate cardiovascular risk.
This review synthesizes current evidence on the cardio-renal axis and outlines internal medicine strategies to mitigate cardiovascular risk in patients with chronic kidney disease.
Chronic Kidney Disease (CKD) is a pervasive health challenge globally, intricately linked to cardiovascular morbidity and mortality. This review paper explores the intricate interplay between the cardiovascular and renal systems, delving into the Cardio-Renal Axis, and highlights internal medicineapproaches to mitigate cardiovascular risks in CKD patients.Recognizing the bidirectional impact of CKD and cardiovascular disease, we aim to synthesize current understanding, identify gaps in knowledge, and propose comprehensive strategies to optimize patient outcomes.The Cardio-Renal Axis forms a complex web of interactions, where impaired renal function not only serves as a consequence but also as a driver of cardiovascular dysfunction.The review elucidates the pathophysiological mechanisms, emphasizing the role of inflammation, oxidative stress, and endothelial dysfunction in this bidirectional relationship.Special attention is given to the evolving landscape of biomarkers and imaging modalities that offer insights into early detection and risk stratification.By dissecting the molecular and cellular crosstalk, we aim to provide a foundation for targeted therapeutic interventions.Internal Medicine Strategies for Cardiovascular Risk Mitigation, This section synthesizes evidence-based internal medicine strategies to confront cardiovascular risks in CKD.It encompasses antihypertensive management, glycemic control, lipid-lowering interventions, and novel therapies targeting inflammation and fibrosis.Additionally, the paper explores the integration of lifestyle modifications and patient-centered care in the comprehensive management of CKD patients at risk for cardiovascular events.By amalgamating current clinical guidelines with emerging research, this review strives to offer a roadmap for clinicians navigating the intricate Cardio-Renal Axis, ultimately aiming for enhanced preventive and therapeutic measures in this high-risk patient population.
No takes yet. Share an insight, caveat, or question.
Begum et al. (2023) conducted a review in Chronic Kidney Disease (CKD) and Cardiovascular Risk. Internal medicine approaches (antihypertensive, glycemic, and lipid management) was evaluated. Comprehensive internal medicine strategies, including blood pressure control, glycemic management, and lipid-lowering therapies, are essential for mitigating the elevated cardiovascular risk in patients with chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: